Welcome to LookChem.com Sign In|Join Free

CAS

  • or

17794-35-3

Post Buying Request

17794-35-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

17794-35-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 17794-35-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,7,7,9 and 4 respectively; the second part has 2 digits, 3 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 17794-35:
(7*1)+(6*7)+(5*7)+(4*9)+(3*4)+(2*3)+(1*5)=143
143 % 10 = 3
So 17794-35-3 is a valid CAS Registry Number.

17794-35-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name N,N-bis(2-chloroethyl)-4-phenylmethoxyaniline

1.2 Other means of identification

Product number -
Other names benzyl-p-(bis-2-chloroethylamino)phenyl ester

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:17794-35-3 SDS

17794-35-3Relevant articles and documents

HYPOXIA ACTIVATED DRUGS OF NITROGEN MUSTARD ALKYLATORS

-

, (2009/12/23)

Hypoxia activated drug compounds having a structure of formula(I) are useful in the treatment of cancer and other hyperproliferative diseases.

Melanocyte-directed enzyme prodrug therapy (MDEPT): Development of a targeted treatment for malignant melanoma

Jordan, Allan M.,Khan, Tariq H.,Osborn, Helen M. I.,Photiou, Andrew,Riley, Patrick A.

, p. 1775 - 1780 (2007/10/03)

A novel prodrug rationally designed to function as a tyrosinase substrate has been synthesised to allow targeted treatment of malignant melanoma. This agent has been evaluated for tyrosinase-mediated drug release, and has been shown to act in the desired

Glucuronide prodrugs of hydroxy compounds for antibody directed enzyme prodrug therapy (adept): A phenol nitrogen mustard carbamate

Schmidt,Florent,Monneret,Straub,Czech,Gerken,Bosslet

, p. 1071 - 1076 (2007/10/03)

A prodrug consisting of a β-D-glucuronic acid linked to a self-immolative spacer (a N-(ortho-hydroxyphenyl)-N-methylcarbamate) and a phenolic nitrogen mustard was synthesised. As this prodrug was easily cleaved by a β-glucuronidase enzyme and displayed lo

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 17794-35-3